GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 745 filers reported holding GLAXOSMITHKLINE PLC in Q3 2016. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,262,000 | -11.3% | 34,292 | -9.2% | 0.02% | -17.4% |
| Q3 2020 | $1,422,000 | -14.0% | 37,786 | -6.8% | 0.02% | -17.9% |
| Q2 2020 | $1,654,000 | +2.1% | 40,550 | -5.2% | 0.03% | -9.7% |
| Q1 2020 | $1,620,000 | -77.2% | 42,760 | -75.9% | 0.03% | -72.8% |
| Q4 2019 | $7,108,000 | -0.1% | 177,603 | +6.5% | 0.11% | +2.7% |
| Q3 2019 | $7,116,000 | +0.1% | 166,732 | -6.1% | 0.11% | -2.6% |
| Q2 2019 | $7,108,000 | -65.4% | 177,603 | -63.9% | 0.11% | -67.1% |
| Q1 2019 | $20,531,000 | -16.2% | 491,295 | -23.4% | 0.35% | -24.7% |
| Q4 2018 | $24,514,000 | -32.0% | 641,569 | -28.5% | 0.46% | -24.9% |
| Q3 2018 | $36,053,000 | -38.1% | 897,510 | -37.9% | 0.61% | -40.0% |
| Q2 2018 | $58,242,000 | -5.8% | 1,444,856 | -8.7% | 1.02% | -10.3% |
| Q1 2018 | $61,812,000 | +7.2% | 1,582,073 | -2.7% | 1.14% | +8.5% |
| Q4 2017 | $57,649,000 | -30.2% | 1,625,293 | -20.2% | 1.05% | -33.5% |
| Q3 2017 | $82,649,000 | -0.7% | 2,035,688 | +5.4% | 1.58% | -6.4% |
| Q2 2017 | $83,247,000 | +10.3% | 1,930,597 | +7.8% | 1.69% | +0.5% |
| Q1 2017 | $75,474,000 | +27.3% | 1,790,184 | +16.3% | 1.68% | +17.0% |
| Q4 2016 | $59,299,000 | -2.1% | 1,539,843 | +9.7% | 1.44% | -8.9% |
| Q3 2016 | $60,541,000 | +5.0% | 1,403,683 | +5.5% | 1.58% | -0.4% |
| Q2 2016 | $57,685,000 | +20.1% | 1,330,992 | +12.4% | 1.59% | +10.4% |
| Q1 2016 | $48,018,000 | +12.6% | 1,184,167 | +12.1% | 1.44% | +3.0% |
| Q4 2015 | $42,632,000 | +12.9% | 1,056,555 | +7.6% | 1.40% | +1.3% |
| Q3 2015 | $37,746,000 | -2.9% | 981,691 | +5.1% | 1.38% | -2.8% |
| Q2 2015 | $38,889,000 | -2.4% | 933,717 | +8.2% | 1.42% | -5.9% |
| Q1 2015 | $39,835,000 | +22.4% | 863,169 | +13.3% | 1.50% | +13.5% |
| Q4 2014 | $32,558,000 | -0.1% | 761,775 | +7.5% | 1.33% | -8.7% |
| Q3 2014 | $32,582,000 | -6.9% | 708,757 | +8.3% | 1.45% | -9.2% |
| Q2 2014 | $34,988,000 | +7.0% | 654,219 | +6.9% | 1.60% | -3.3% |
| Q1 2014 | $32,690,000 | +10.0% | 611,824 | +9.9% | 1.66% | +0.7% |
| Q4 2013 | $29,731,000 | +19.4% | 556,867 | +12.2% | 1.64% | +6.6% |
| Q3 2013 | $24,897,000 | +10.9% | 496,258 | +10.5% | 1.54% | -0.1% |
| Q2 2013 | $22,441,000 | – | 449,090 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |